Sandra Calvin

Insider Reports History

Location
3611 Valley Center Drive, Suite 300, San Diego, CA
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandra Calvin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Common Stock 54.4K $1.36M $25.00 Feb 11, 2025 Direct
Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Employee stock option (right to buy) 0 Feb 11, 2025 Direct

Insider Reports Filed by Sandra Calvin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TVTX Travere Therapeutics, Inc. Feb 11, 2025 13 -$608K 4 Feb 12, 2025 SVP, CHIEF ACCOUNTING OFFICER
TVTX Travere Therapeutics, Inc. Jan 31, 2025 3 -$67.4K 4 Feb 4, 2025 SVP, CHIEF ACCOUNTING OFFICER
TVTX Travere Therapeutics, Inc. Jan 22, 2025 1 -$17.5K 4 Jan 23, 2025 SVP, CHIEF ACCOUNTING OFFICER
TVTX Travere Therapeutics, Inc. Dec 26, 2024 3 -$68.2K 4 Dec 27, 2024 SVP, CHIEF ACCOUNTING OFFICER
TVTX Travere Therapeutics, Inc. Nov 25, 2024 3 -$31.2K 4 Nov 25, 2024 SVP, CHIEF ACCOUNTING OFFICER
TVTX Travere Therapeutics, Inc. Jan 31, 2024 4 -$24.1K 4 Feb 2, 2024 SVP, CHIEF ACCOUNTING OFFICER
TVTX Travere Therapeutics, Inc. Jan 23, 2024 1 -$8.25K 4 Jan 25, 2024 SVP, CHIEF ACCOUNTING OFFICER
TVTX Travere Therapeutics, Inc. May 10, 2023 2 -$9.2K 4 May 12, 2023 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. Jan 31, 2023 4 -$44.4K 4 Feb 2, 2023 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. Jan 24, 2023 2 -$24K 4 Jan 26, 2023 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. Sep 13, 2022 1 -$9.77K 4 Sep 15, 2022 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. May 10, 2022 2 -$19.1K 4 May 12, 2022 SVP, Chief Accounting Officer
TVTX Travere Therapeutics, Inc. Jan 31, 2022 3 -$21.2K 4 Feb 2, 2022 VP, Corp Controller and CAO
TVTX Travere Therapeutics, Inc. Jan 24, 2022 1 -$23K 4 Jan 26, 2022 VP, Corp Controller and CAO
TVTX Travere Therapeutics, Inc. Sep 15, 2021 0 $0 3 Sep 23, 2021 VP, Corp Controller and CAO